9/15/2022 8:42:52 AM
Celsion Completes Enrollment Of Phase I/II OVATION 2 Study With GEN-1 In Advanced Ovarian Cancer
7/19/2022 8:41:17 AM
Celsion Appoints Corinne Le Goff As President And CEO
7/19/2022 8:38:32 AM
Celsion Corporation Reports Inducement Grants Under NASDQ Listing Rule 5646(c)(4)
6/21/2022 8:40:26 AM
Celsion: Data Safety Monitoring Board Recommends To Continue Dosing Patients In Phase II Part Of OVATION 2 Study
6/21/2021 8:14:26 AM
Celsion Corporation Enters $10 Mln Strategic Loan Facility With Silicon Valley Bank
6/9/2021 8:10:00 AM
Celsion Appoints Christine Pellizzari To Board
6/8/2021 8:12:28 AM
Celsion Appoints Stacy Lindborg To Its Board
3/19/2021 9:09:04 AM
Celsion 2020 Net Loss $21.5 Mln Or $0.67/Shr Vs Loss $16.8 Mln Or $0.77/Shr Last Year